Moody, R.; Wilson, K.; Kampan, N.C.; McNally, O.M.; Jobling, T.W.; Jaworowski, A.; Stephens, A.N.; Plebanski, M.
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy. Cancers 2021, 13, 4201.
https://doi.org/10.3390/cancers13164201
AMA Style
Moody R, Wilson K, Kampan NC, McNally OM, Jobling TW, Jaworowski A, Stephens AN, Plebanski M.
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy. Cancers. 2021; 13(16):4201.
https://doi.org/10.3390/cancers13164201
Chicago/Turabian Style
Moody, Rhiane, Kirsty Wilson, Nirmala Chandralega Kampan, Orla M. McNally, Thomas W. Jobling, Anthony Jaworowski, Andrew N. Stephens, and Magdalena Plebanski.
2021. "Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy" Cancers 13, no. 16: 4201.
https://doi.org/10.3390/cancers13164201
APA Style
Moody, R., Wilson, K., Kampan, N. C., McNally, O. M., Jobling, T. W., Jaworowski, A., Stephens, A. N., & Plebanski, M.
(2021). Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy. Cancers, 13(16), 4201.
https://doi.org/10.3390/cancers13164201